Urological Research

, Volume 37, Issue 3, pp 133–139 | Cite as

Effects of calcium supplementation on body weight reduction in overweight calcium stone formers

  • Viviane Barcellos Menon
  • Alessandra Calábria Baxmann
  • Leila Froeder
  • Lígia Araújo Martini
  • Ita Pfeferman Heilberg
Original Paper

Abstract

A randomized, placebo-controlled trial was conducted in overweight calcium stone-forming (CSF) patients, to evaluate the effect of calcium supplementation associated with a calorie-restricted diet on body weight (BW) and fat reduction and its potential changes upon serum and urinary parameters. Fifteen patients were placed on a hypocaloric diet for 3 months, supplemented with either calcium carbonate (CaCO3, n = 8) or placebo (n = 7), 500 mg bid. Blood and 24-h urine samples were collected and body composition was assessed at baseline and after the intervention. At the end of the study, final BW was significantly lower vs baseline in both CaCO3 (74 ± 14 vs. 80 ± 14 kg, P = 0.01) and placebo groups (80 ± 10 vs. 87 ± 9 kg, P = 0.02) but the mean percentage of loss of body weight and body fat did not differ between CaCO3 and placebo (7.0 ± 2.0 vs. 8.0 ± 3.0%, P = 0.40 and 13.0 ± 7.0 vs. 13.0 ± 10.0%; P = 0.81, respectively). After CaCO3 or placebo, no significant differences versus baseline were observed for urinary parameters in both CaCO3 and placebo, except for a higher mean urinary citrate in placebo group. These data suggest that increasing calcium intake by calcium carbonate supplementation did not contribute to a further reduction of BW and fat in overweight CSF patients submitted to a hypocaloric diet nor altered urinary lithogenic parameters.

Keywords

Calcium intake Weight loss Kidney stones Vitamin D 

References

  1. 1.
    Coe FL, Evan A, Worcester E (2005) Kidney stone disease. J Clin Invest 115:2598–2608. doi:10.1172/JCI26662 PubMedCrossRefGoogle Scholar
  2. 2.
    Moe OW (2006) Kidney stones: pathophysiology and medical management. Lancet 367:333–344. doi:10.1016/S0140-6736(06)68071-9 PubMedCrossRefGoogle Scholar
  3. 3.
    Curhan GC, Willet WC, Rimm EB, Speizer FE, Stampfer MJ (1998) Body size and risk of kidney stones. J Am Soc Nephrol 9:1645–1652PubMedGoogle Scholar
  4. 4.
    Siener R, Glatz S, Nicolay C, Hesse A (2004) The role of overweight and obesity in calcium oxalate stone formation. Obes Res 12:106–113. doi:10.1038/oby.2004.14 PubMedCrossRefGoogle Scholar
  5. 5.
    Taylor EN, Stampfer MJ, Curhan GC (2005) Obesity, weight gain, and the risk of kidney stones. JAMA 293:455–462. doi:10.1001/jama.293.4.455 PubMedCrossRefGoogle Scholar
  6. 6.
    Maalouf NM, Sakhaee K, Parks JH, Coe FL, Adams-Huet B, Pak CYC (2004) Association of urinary pH with body weight in nephrolithiasis. Kidney Int 65:1422–1425. doi:10.1111/j.1523-1755.2004.00522.x PubMedCrossRefGoogle Scholar
  7. 7.
    Zemel MB, Thompson W, Milstead A, Morris K, Campbell P (2004) Calcium and dairy acceleration of weight and fat loss during energy restriction in obese adults. Obes Res 12:582–590. doi:10.1038/oby.2004.67 PubMedCrossRefGoogle Scholar
  8. 8.
    Zemel MB, Richards J, Mathis S, Milstead A, Gebhardt L, Silva E (2005) Dairy augmentation of total and central fat loss in obese subjects. Int J Obes 29:391–397. doi:10.1038/sj.ijo.0802880 CrossRefGoogle Scholar
  9. 9.
    Zemel MB, Richards J, Milstead A, Campbell P (2005) Effects of calcium and dairy on body composition and weight loss in African-American Adults. Obes Res 13:1218–1225. doi:10.1038/oby.2005.144 PubMedCrossRefGoogle Scholar
  10. 10.
    Zemel MB (2003) Role of dietary calcium and dairy products in modulating adiposity. Lipids 38:139–146. doi:10.1007/s11745-003-1044-6 PubMedCrossRefGoogle Scholar
  11. 11.
    Zemel MB (2003) Mechanisms of dairy modulation of adiposity. J Nutr 133:252S–256SPubMedGoogle Scholar
  12. 12.
    Shahkhalili Y, Murset C, Meirim I, Duruz E, Guinchard S, Cavadini C et al (2001) Calcium supplementation of chocolate: effect on cocoa butter digestibility and blood lipids in humans. Am J Clin Nutr 73:246–252PubMedGoogle Scholar
  13. 13.
    Vaskonen T (2003) Dietary minerals and modification of cardiovascular risk factors. J Nutr Biochem 14:492–506. doi:10.1016/S0955-2863(03)00074-3 PubMedCrossRefGoogle Scholar
  14. 14.
    Ricci TA, Chowdhury HA, Heymsfield SB, Stahl T, Pierson RN, Shapses AS (1998) Calcium supplementation suppresses bone turnover during weight reduction in postmenopausal women. J Bone Miner Res 13:1045–1050. doi:10.1359/jbmr.1998.13.6.1045 PubMedCrossRefGoogle Scholar
  15. 15.
    Shapses SA, Heshka S, Heymsfield SB (2004) Effect of calcium on weight and fat loss in women. J Clin Endocrinol Metab 89:632–637. doi:10.1210/jc.2002-021136 PubMedCrossRefGoogle Scholar
  16. 16.
    Gunther CW, Legowski PA, Lyle RM, McCabe GP, Eagan MS, Peacock M et al (2005) Dairy products do not lead to alterations in body weight or fat mass in young women in a 1-y intervention. Am J Clin Nutr 81:751–756PubMedGoogle Scholar
  17. 17.
    Reid IR, Horne A, Mason B, Ames R, Bava U, Gamble GD (2005) Effects of calcium supplementation on body weight and blood pressure in normal older women: a randomized controlled trial. J Clin Endocrinol Metab 90:3824–3829. doi:10.1210/jc.2004-2205 PubMedCrossRefGoogle Scholar
  18. 18.
    Lorenzen JK, Molgaard C, Michaensen KF, Astrup A (2006) Calcium supplementation for 1 y does not reduce body weight or fat mass in young girls. Am J Clin Nutr 83:18–23PubMedGoogle Scholar
  19. 19.
    Riedt CS, Schlussel Y, Von Thun N, Ambia-Sobhan H, Stahl T, Field MP et al (2007) Premenopausal overweight women do not lose bone during moderate weight loss with adequate or higher calcium intake. Am J Clin Nutr 85:972–980PubMedGoogle Scholar
  20. 20.
    Curhan GC, Willet WC, Rimm EB, Stampfer MJ (1993) A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 328:833–838. doi:10.1056/NEJM199303253281203 PubMedCrossRefGoogle Scholar
  21. 21.
    Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U et al (2002) Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 346:77–84. doi:10.1056/NEJMoa010369 PubMedCrossRefGoogle Scholar
  22. 22.
    Domrongkitchaiporn S, Sopassathit W, Stitchantrakul W, Prapaipanich S, Ingsathit A, Rajatanavin R (2004) Schedule of taking calcium supplement and the risk of nephrolithiasis. Kidney Int 65:1835–1841. doi:10.1111/j.1523-1755.2004.00587.x PubMedCrossRefGoogle Scholar
  23. 23.
    National Kidney Foundation–Kidney Disease Outcome Quality Iniciative (2000) Clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis 35:17–37CrossRefGoogle Scholar
  24. 24.
    Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419. doi:10.1007/BF00280883 PubMedCrossRefGoogle Scholar
  25. 25.
    Tiselius HG (1991) Aspects on estimation of the risk of calcium oxalate crystallization in urine. Urol Int 47:255–259PubMedCrossRefGoogle Scholar
  26. 26.
    Dos Santos LC, Martini LA, Cintra Ide P, Fisberg M (2005) Relationship between calcium intake and body mass index in adolescents. Arch Latinoam Nutr 55:345–349PubMedGoogle Scholar
  27. 27.
    Zemel MB, Shi H, Greer B, Dirienzo D, Zemel P (2000) Regulation of adiposity by dietary calcium. FASEB J 14:1132–1138PubMedGoogle Scholar
  28. 28.
    Shi H, Dirienzo D, Zemel MB (2001) Effects of dietary calcium on adipocyte lipid metabolism and body weight regulation in energy-restricted aP2-agouti transgenic mice. FASEB J 15:291–293PubMedGoogle Scholar
  29. 29.
    Pittas AG, Lau J, Hu FB, Dawson-Hughes B (2007) Review: the role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92:2017–2029. doi:10.1210/jc.2007-0298 PubMedCrossRefGoogle Scholar
  30. 30.
    Melanson EL, Donahoo WT, Dong F, Ida T, Zemel MB (2005) Effect of low-and high-calcium dairy- based diets on macronutrient oxidation in humans. Obes Res 13:2102–2112. doi:10.1038/oby.2005.261 PubMedCrossRefGoogle Scholar
  31. 31.
    Ryan AS, Berman DM, Nicklas BJ, Sinha M, Gingerich RL, Meneilly GS et al (2003) Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity. Diabetes Care 26:2383–2388. doi:10.2337/diacare.26.8.2383 PubMedCrossRefGoogle Scholar
  32. 32.
    Meier U, Gressner AM (2004) Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem 50:1511–1525. doi:10.1373/clinchem.2004.032482 PubMedCrossRefGoogle Scholar
  33. 33.
    Grundy SM (2004) Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 89:2595–2600. doi:10.1210/jc.2004-0372 PubMedCrossRefGoogle Scholar
  34. 34.
    Ryan AS, Nicklas BJ, Berman DM, Elahi D (2003) Adiponectin levels do not change with moderate dietary induced weight loss and exercise in obese postmenopausal women. Int J Obes 27:1066–1071. doi:10.1038/sj.ijo.0802387 CrossRefGoogle Scholar
  35. 35.
    Heller HJ, Doerner MF, Brinkley LJ, Adams-Huet B, Pak CYC (2003) Effect of dietary calcium on stone forming propensity. J Urol 169:470–474. doi:10.1016/S0022-5347(05)63935-3 PubMedCrossRefGoogle Scholar
  36. 36.
    Domrongkitchaiporn S, Ongphiphadhanakul B, Stitchantrakul W, Chansirikarn S, Puavilai G, Rajatanavin R (2002) Risk of calcium oxalate nephrolithiasis in postmenopausal women supplemented with calcium or combined calcium and estrogen. Maturitas 41:149–156. doi:10.1016/S0378-5122(01)00277-8 PubMedCrossRefGoogle Scholar
  37. 37.
    Lewandowski S, Rodgers A (2004) Renal response to lithogenic and anti-lithogenic supplement challenges in a stone-free population group. J Ren Nutr 14:170–179. doi:10.1053/j.jrn.2004.04.007 PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Viviane Barcellos Menon
    • 1
  • Alessandra Calábria Baxmann
    • 1
  • Leila Froeder
    • 1
  • Lígia Araújo Martini
    • 3
  • Ita Pfeferman Heilberg
    • 2
  1. 1.Nutrition ProgramUniversidade Federal de São PauloSão PauloBrazil
  2. 2.Nephrology DivisionUniversidade Federal de São PauloSão PauloBrazil
  3. 3.Nutrition DepartmentUniversidade de São PauloSão PauloBrazil

Personalised recommendations